1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Sular® Extended Release Tablets, 30 mg: new trials by email Literature Review of Sular® Extended Release Tablets, 30 mg trials Research Report on Sular® Extended Release Tablets, 30 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg Nisoldipine Extended-release Tablets, 30 mg, Sular® Extended Release Tablets, 30 mg - Healthy | Phase 1 | Completed | Mylan Pharmaceuticals Inc | 78 | 2007-06-01 | 2009-09-28 |
United States (1)